Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Atopic Eczema”

Showing 20 of 0 results

Not applicableStudy completedNCT05140239
What this trial is testing

Effects of Abrocitinib Treatment on Skin Barrier Function

Who this might be right for
Atopic Dermatitis
Prof. Dr. Stephan Weidinger 20
Testing effectiveness (Phase 2)Looking for participantsNCT07399067
What this trial is testing

A Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Innovent Biologics (Suzhou) Co. Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT02780167
What this trial is testing

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pfizer 269
Testing effectiveness (Phase 2)Study completedNCT04893707
What this trial is testing

The Study of CM310 in Patients With Atopic Dermatitis

Who this might be right for
Moderate-to-severe Atopic Dermatitis
Keymed Biosciences Co.Ltd 127
Early research (Phase 1)Study completedNCT04975438
What this trial is testing

Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
GlaxoSmithKline 34
Large-scale testing (Phase 3)Active Not RecruitingNCT05492578
What this trial is testing

Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials

Who this might be right for
Dermatitis Atopic
Sanofi 1,856
Early research (Phase 1)Not Yet RecruitingNCT07549984
What this trial is testing

IBI3033 in Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Innovent Biologics (Suzhou) Co. Ltd. 16
Large-scale testing (Phase 3)Active Not RecruitingNCT03989206
What this trial is testing

Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Moderate-to-Severe Atopic Dermatitis
Galderma R&D 1,700
Large-scale testing (Phase 3)Study completedNCT03733301
What this trial is testing

Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 329
Testing effectiveness (Phase 2)Ended earlyNCT03568071
What this trial is testing

Assess Efficacy, Safety, Tolerability and Pharmacokinetics (PK)/Pharmacodynamics (PD) of MOR106 in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Lakefront Biotherapeutics NV 207
Testing effectiveness (Phase 2)Study completedNCT01299610
What this trial is testing

Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo

Who this might be right for
Dermatitis, Atopic
GlaxoSmithKline 25
Large-scale testing (Phase 3)Looking for participantsNCT06723080
What this trial is testing

Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Moderate to Severe Atopic Dermatitis
Jiangsu vcare pharmaceutical technology co., LTD 480
Early research (Phase 1)Ended earlyNCT04211415
What this trial is testing

Phase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Daiichi Sankyo Co., Ltd. 8
Large-scale testing (Phase 3)Study completedNCT02835170
What this trial is testing

Study of Autologous Total Immunoglobulin G Therapy for Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Ajou University School of Medicine 51
Testing effectiveness (Phase 2)Looking for participantsNCT07211542
What this trial is testing

Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Moderate-to-severe Atopic Dermatitis
Guangdong Hengrui Pharmaceutical Co., Ltd 75
Post-approval studies (Phase 4)Study completedNCT00666159
What this trial is testing

Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Astellas Pharma Inc 226
Post-approval studies (Phase 4)Study completedNCT00690105
What this trial is testing

Protopic Ointment in Adult Atopic Eczema of the Face

Who this might be right for
Dermatitis, Atopic
Astellas Pharma Inc 577
Testing effectiveness (Phase 2)Active Not RecruitingNCT05769777
What this trial is testing

Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis Atopic
Sanofi 999
Large-scale testing (Phase 3)Study completedNCT03363854
What this trial is testing

Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3

Who this might be right for
Atopic Dermatitis
LEO Pharma 380
Large-scale testing (Phase 3)Study completedNCT04587453
What this trial is testing

Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
LEO Pharma 106
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation